These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
621 related articles for article (PubMed ID: 28371513)
21. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities. Zand L; Specks U; Sethi S; Fervenza FC Adv Chronic Kidney Dis; 2014 Mar; 21(2):182-93. PubMed ID: 24602467 [TBL] [Abstract][Full Text] [Related]
22. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management. Plumb LA; Oni L; Marks SD; Tullus K Pediatr Nephrol; 2018 Jan; 33(1):25-39. PubMed ID: 28062909 [TBL] [Abstract][Full Text] [Related]
27. Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement. Chen Y; Bao H; Liu Z; Zhang H; Zeng C; Liu Z; Hu W J Nephrol; 2014 Apr; 27(2):159-64. PubMed ID: 24570072 [TBL] [Abstract][Full Text] [Related]
28. Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial. Jones RB; Hiemstra TF; Ballarin J; Blockmans DE; Brogan P; Bruchfeld A; Cid MC; Dahlsveen K; de Zoysa J; Espigol-Frigolé G; Lanyon P; Peh CA; Tesar V; Vaglio A; Walsh M; Walsh D; Walters G; Harper L; Jayne D; Ann Rheum Dis; 2019 Mar; 78(3):399-405. PubMed ID: 30612116 [TBL] [Abstract][Full Text] [Related]
29. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. Nachman PH; Hogan SL; Jennette JC; Falk RJ J Am Soc Nephrol; 1996 Jan; 7(1):33-9. PubMed ID: 8808107 [TBL] [Abstract][Full Text] [Related]
30. Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial. Tuin J; Stassen PM; Bogdan DI; Broekroelofs J; van Paassen P; Cohen Tervaert JW; Sanders JS; Stegeman CA Clin J Am Soc Nephrol; 2019 Jul; 14(7):1021-1028. PubMed ID: 31253599 [TBL] [Abstract][Full Text] [Related]
31. Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Miloslavsky EM; Niles JL; Wallace ZS; Cortazar FB; Fernandes A; Laliberte K; Stone JH Semin Arthritis Rheum; 2018 Oct; 48(2):288-292. PubMed ID: 29530330 [TBL] [Abstract][Full Text] [Related]
32. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR; Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882 [TBL] [Abstract][Full Text] [Related]
34. [Diagnosis and management of small vessel vasculitides]. Pettersson T; Karjalainen A Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753 [TBL] [Abstract][Full Text] [Related]
35. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Sinico RA; Di Toma L; Radice A Autoimmun Rev; 2013 Feb; 12(4):477-82. PubMed ID: 22921791 [TBL] [Abstract][Full Text] [Related]
36. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center. Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332 [TBL] [Abstract][Full Text] [Related]
37. Mycophenolate mofetil for induction and maintenance of remission in naïve patients with granulomatosis with polyangiitis without renal involvement. Emad Y; Ragab Y; Rasker JJ Reumatol Clin (Engl Ed); 2020; 16(4):294-297. PubMed ID: 29778666 [TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study. Sacri AS; Chambaraud T; Ranchin B; Florkin B; Sée H; Decramer S; Flodrops H; Ulinski T; Allain-Launay E; Boyer O; Dunand O; Fischbach M; Hachulla E; Pietrement C; Le Pogamp P; Stephan JL; Belot A; Nivet H; Nobili F; Guillevin L; Quartier P; Deschênes G; Salomon R; Essig M; Harambat J Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i104-12. PubMed ID: 25676121 [TBL] [Abstract][Full Text] [Related]
39. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab. Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574 [TBL] [Abstract][Full Text] [Related]
40. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L; N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]